Transgene S.a annual debt-to-assets ratio
2021
2022
2023
2024
2025
Transgene S.a Debt-to-Assets Ratio Growth & History (TNG)
Transgene S.a's debt-to-assets ratio was 0.01 for fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | −0.23 | −93.99% |
| 2024 | 2024-12-31 | 0.25 | −0.14 | −35.55% |
| 2023 | 2023-12-31 | 0.38 | 0.18 | +87.97% |
| 2022 | 2022-12-31 | 0.20 | 0.04 | +24.57% |
| 2021 | 2021-12-31 | 0.16 | — | — |
Transgene S.a quarterly debt-to-assets ratio
Q4.24
Q4.25
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.00 | −0.00 | — |
| Q4 2024 | 2024-12-31 | 0.00 | — | — |
Transgene S.a debt-to-assets ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Transgene S.a's debt-to-assets ratio decreased from 0.16 to 0.01, a change of −0.15. The latest reported quarter, Q4 2025, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗Community posts
Transgene reports €92.8 million in liquidity as vaccine development advances
Transgene ($TNG) reported €92.8 million in cash, cash equivalents and other current financial assets at its half-year end, compared with €111.9 million at the start of the year. First-half cash burn increased to €20.3 million from €18.8 mil ...
